Christopher W. Seder
Rush University Medical Center(US)Alexion Pharma (Switzerland)(CH)Rush University(US)
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Pleural and Pulmonary Diseases, Cancer Genomics and Diagnostics, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model(2016)254 cited
- → The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes(2016)210 cited
- → Upregulated INHBA Expression May Promote Cell Proliferation and Is Associated with Poor Survival in Lung Adenocarcinoma(2009)180 cited
- → Understanding barriers to lung cancer screening in primary care(2020)101 cited
- → Chest wall reconstruction after extended resection(2016)100 cited
- → INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma(2009)95 cited